Xie, Yan

High-dimensional characterization of post-acute sequelae of COVID-19

Al-Aly, Z., Xie, Y., & Bowe, B. (2021) · Nature

Long-Term Effects of COVID-19COVID-19 Clinical Research Studies

Cited by 1,518

Long COVID after breakthrough SARS-CoV-2 infection

Al-Aly, Z., Bowe, B., & Xie, Y. (2022) · Nature Medicine

Long-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research

Cited by 866

Long-term neurologic outcomes of COVID-19

Xu, E., Xie, Y., & Al-Aly, Z. (2022) · Nature Medicine

Long-Term Effects of COVID-19COVID-19 Clinical Research Studies

Cited by 530

The 2016 global and national burden of diabetes mellitus attributable to PM 2·5 air pollution

Bowe, B., Xie, Y., Li, T., Yan, Y., Xian, H., & Al-Aly, Z. (2018) · The Lancet Planetary Health

Air Quality and Health ImpactsEnergy and Environment Impacts

Cited by 371

Burden of Cause-Specific Mortality Associated With PM 2.5 Air Pollution in the United States

Bowe, B., Xie, Y., Yan, Y., & Al-Aly, Z. (2019) · JAMA Network Open

Air Quality and Health ImpactsIndoor Air Quality and Microbial Exposure

Cited by 367

Mapping the effectiveness and risks of GLP-1 receptor agonists

Xie, Y., Choi, T., & Al-Aly, Z. (2025) · Nature Medicine

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 300

High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans

Bowe, B., Xie, Y., Xian, H., Balasubramanian, S., Zayed, M. A., & Al-Aly, Z. (2016) · Clinical Journal of the American Society of Nephrology

Lipoproteins and Cardiovascular HealthChronic Kidney Disease and Diabetes

Cited by 213

Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records

Xie, Y., Bowe, B., Xian, H., Loux, T., McGill, J. B., & Al-Aly, Z. (2023) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 104